CD47 and neoplasm: Assessing CD47 expression of 75 human glioma specimens of different grade with immunohistochemical staining revealed that less than 30% tumor cells are CD47-positive in grade 4 gliomas, and the percentage is even lower in low-grade gliomas [32].